Avior Wealth Management’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-214
Closed -$19.7K 2457
2024
Q1
$19.7K Sell
214
-317
-60% -$30.4K ﹤0.01% 1607
2023
Q4
$56.1K Hold
531
﹤0.01% 713
2023
Q3
$57.7K Hold
531
﹤0.01% 739
2023
Q2
$57.4K Hold
531
﹤0.01% 729
2023
Q1
$66.2K Buy
+531
New +$72.9K ﹤0.01% 716

Other funds holding BNTX

Avior Wealth Management's BNTX Position: Q2 2024 in Review

Avior Wealth Management sold out of BioNTech (BNTX) in Q2 2024, closing a stake of 214 shares — an estimated $19.7K sold.

Avior Wealth Management first reported a position in BNTX in Q1 2023 and held it in 5 quarters. The position peaked at $66.2K in Q1 2023. 286 funds tracked by Wall St. Rank hold BNTX as of Q2 2024.

  • Avior Wealth Management reported no remaining BioNTech position as of Q2 2024 after selling out during the quarter.
  • Avior Wealth Management sold 214 BioNTech shares in Q2 2024, an estimated $19.7K.
  • Avior Wealth Management first reported a position in BioNTech in Q1 2023 and held it in 5 quarters.
  • Avior Wealth Management's BioNTech position peaked at $66.2K in Q1 2023.
  • 286 funds tracked by Wall St. Rank held BioNTech as of Q2 2024.

Based on Avior Wealth Management's 13F filing for Q2 2024, filed 13 Aug 2024.